Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer

Journal of Surgical Oncology

Volumn 103, Issue 6, 2011, Pages 602-606

  Alberini, Jean Louis ^a   Edeline, Veronique ^a   Giraudet, Anne Laure ^a   Champion, Laurence ^a   Paulmier, Benoit ^a   Madar, Olivier ^a   Poinsignon, Anne ^a   Bellet, Dominique ^a   Pecking, Alain Paul ^a  

^a INSTITUT CURIE   (France)

Author keywords

hybrid imaging; oncology

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER RECURRENCE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE;

ADULT; AGED; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASMS; NEUROENDOCRINE TUMORS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79953847178     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21695     Document Type: Article

References (25)

1. Mariani G, Bruselli L, Kuwert T, et al.: A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 2010 Feb 25. [Epub ahead of print] PubMed PMID: 20182712.
2. O'Connor MK, Kemp BJ,: Single-photon emission computed tomography/computed tomography: Basic instrumentation and innovations. Semin Nucl Med 2006; 36: 258-266. (Pubitemid 44300996)
3. Von Schulthess GK,: Integrated modality imaging with PET-CT and SPECT-CT: CT issues. Eur Radiol 2005; 15: D121-D126.
4. Hasegawa BH, Wong KH, Iwata K, et al.: Dual-modality imaging of cancer with SPECT/CT. Technol Cancer Res Treat 2002; 1: 449-458. (Pubitemid 36548521)
5. Krausz Y, Keidar Z, Kogan I, et al.: SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf) 2003; 59: 565-573. (Pubitemid 37357615)
6. Schillaci O, Danieli R, Manni C, et al.: Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation ? Nucl Med Commun 2004; 25: 705-710. (Pubitemid 38901688)
7. Schillaci O, Simonetti G,: Fusion imaging in nuclear medicine- Applications of dual-modality systems in oncology. Cancer Biother Radiopharm 2004; 19: 1-10. (Pubitemid 38352280)
8. Castaldi P, Rufini V, Treglia G, et al.: Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours. Radiol Med 2008; 113: 1056-1067.
9. Even-Sapir E, Keidar Z, Bar-Shalom R,: Hybrid imaging (SPECT/CT and PET/CT)-Improving the diagnostic accuracy of functional/metabolic and anatomic imaging. Semin Nucl Med 2009; 39: 264-275.
10. Patton JA, Townsend DW, Hutton BF,: Hybrid imaging technology: From dreams and vision to clinical devices. Semin Nucl Med 2009; 39: 247-263.
11. Spanu A, Solinas ME, Chessa F, et al.: 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: Incremental value versus planar imaging. J Nucl Med 2009; 50: 184-190.
12. Chowdhury FU, Scarsbrook AF,: The role of hybrid SPECT-CT in oncology: Current and emerging clinical applications. Clin Radiol 2008; 63: 241-251.
13. Wong KK, Zarzhevsky N, Cahill JM, et al.: Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma. Br J Radiol 2009; 82: 860-876.
14. Ingui CJ, Shah NP, Oates ME,: Endocrine neoplasm scintigraphy: Added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Clin Nucl Med 2006; 31: 665-672. (Pubitemid 44624550)
15. Patton JA, Turkington TG,: SPECT/CT physical principles and attenuation correction. J Nucl Med Technol 2008; 36: 1-10. (Pubitemid 351520586)
16. Tharp K, Israel O, Hausmann J, et al.: Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging 2004; 31: 1435-1442. (Pubitemid 39361941)
17. Von Schulthess GK,: Positron emission tomography versus positron emission tomography/computed tomography: From "unclear" to "new-clear" medicine. Mol Imaging Biol 2004; 6: 183-187.
18. Berthelsen AK, Holm S, Loft A, et al.: PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 2005; 32: 1167-1175. (Pubitemid 41355943)
19. Buck AK, Nekolla S, Ziegler S, et al.: SPECT/CT. J Nucl Med 2008; 49: 1305-1319.
20. Bybel B, Brunken RC, DiFilippo FP, et al.: SPECT/CT imaging: Clinical utility of an emerging technology. Radiographics 2008; 28: 1097-1113.
21. Pecking AP, Wartski M, Cluzan RV, et al.: SPECT-CT fusion imaging radionuclide lymphoscintigraphy: Potential for limb lymphedema assessment and sentinel node detection in breast cancer. Cancer Treat Res 2007; 135: 79-84.
22. Patel CN, Chowdhury FU, Scarsbrook AF,: Hybrid SPECT/CT: The end of "unclear" medicine. Postgrad Med J 2009; 85: 606-613.
23. Bockisch A, Freudenberg LS, Schmidt D, et al.: Hybrid imaging by SPECT/CT and PET/CT: Proven outcomes in cancer imaging. Semin Nucl Med 2009; 39: 276-289.
24. Maurer AH,: Combined imaging modalities: PET/CT and SPECT/CT. Health Phys 2008; 95: 571-576.
25. Delbeke D, Schöder H, Martin WH, et al.: Hybrid imaging (SPECT/CT and PET/CT): Improving therapeutic decisions. Semin Nucl Med 2009; 39: 308-340.